Form S-3 Pulmatrix Inc For: 4 June
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pulmatrix Inc (PULM)
Pulmatrix Inc stock price live, this page displays NASDAQ PULM stock exchange data. View the PULM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Pulmatrix Inc real time stock price chart below.
What Is the Pulmatrix Inc Stock Price Today?
The Pulmatrix Inc stock price today is 1.6017.
What Is the Stock Symbol for Pulmatrix Inc?
The stock symbol for Pulmatrix Inc is "PULM."
What Stock Exchange Does Pulmatrix Inc Trade On?
Pulmatrix Inc is listed and trades on the NASDAQ stock exchange.
Is Pulmatrix Inc a Good Stock to Buy?
Determining whether Pulmatrix Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PULM quote. (ISIN: US74584P3010)
What Is the Pulmatrix Inc Stock Price Today?
The Pulmatrix Inc stock price today is 1.6017.
What Is the Stock Symbol for Pulmatrix Inc?
The stock symbol for Pulmatrix Inc is "PULM."
What Stock Exchange Does Pulmatrix Inc Trade On?
Pulmatrix Inc is listed and trades on the NASDAQ stock exchange.
Is Pulmatrix Inc a Good Stock to Buy?
Determining whether Pulmatrix Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PULM quote. (ISIN: US74584P3010)
1.6017
+0.0317(+2.02%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.5775
1.6017
52 wk Range
1.1600
6.4932
PULM is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.57751.6017
52 wk Range
1.16006.4932
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PULM Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
- Form 10Q Pulmatrix Inc For: 15 May
- Investing.com
- Form 8K Pulmatrix Inc For: 27 March
- Investing.com
- Form 8K Pulmatrix Inc For: 15 May
- Investing.com
- Form S-3 Pulmatrix Inc For: 4 June
- Investing.com
- Form 10Q Pulmatrix Inc For: 15 May
- Investing.com
- Form 8K Pulmatrix Inc For: 15 May
- Investing.com
- Form 8K Pulmatrix Inc For: 21 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Earnings
Latest Release
May 19, 2026
EPS / Forecast
-0.32 / --
Revenue / Forecast
-- / --
Compare PULM to Peers and Sector
Metrics to compare | PULM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPULMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.3x | −5.1x | −0.4x | |
PEG Ratio | −0.02 | −0.06 | 0.00 | |
Price/Book | 2.2x | 1.1x | 2.6x | |
Price / LTM Sales | - | 6.8x | 3.1x | |
Upside (Analyst Target) | - | 80.2% | 51.8% | |
Fair Value Upside | Unlock | 0.6% | 7.5% | Unlock |
Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor compounds. The company was founded in 2003 and is headquartered in Framingham, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Pulmatrix (PULM) Stock Price Today?
The Pulmatrix stock price today is 1.6017 USD.
What Stock Exchange Does Pulmatrix Trade On?
Pulmatrix is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Pulmatrix?
The stock symbol for Pulmatrix is "PULM."
What Is the Pulmatrix Market Cap?
As of today, Pulmatrix market cap is 5.8100M USD.
What Is Pulmatrix's Earnings Per Share (TTM)?
The Pulmatrix EPS (TTM) is -1.2392.
When Is the Next Pulmatrix Earnings Date?
Pulmatrix will release its next earnings report on Aug 12, 2026.
From a Technical Analysis Perspective, Is PULM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Pulmatrix Stock Split?
Pulmatrix has split 3 times.
How Many Employees Does Pulmatrix Have?
Pulmatrix has 2 employees.
What is the current trading status of Pulmatrix (PULM)?
As of Jul 16, 2026, Pulmatrix (PULM) is trading at a price of 1.6017 USD, with a previous close of 1.5700 USD. The stock has fluctuated within a day range of 1.5775 USD to 1.6017 USD, while its 52-week range spans from 1.1600 USD to 6.4932 USD.
What Is the PULM Premarket Price?
PULM's last pre-market stock price is 1.5297 USD. The pre-market share volume is 40.0000, and the stock has decreased by -0.0403, or -2.5700%.
What Is the PULM After Hours Price?
PULM's last after hours stock price is 1.5370 USD, the stock has decreased by -0.0330, or -2.1000%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.